CASE COMMENTS: UNILATERAL PRACTICES - DOMINANT POSITION - DISPARAGEMENT - INTERIM MEASURES:

Interim measures: The French Competition Council enjoins a pharmaceutical company to abstain from disparaging practices against a generic medicines manufacturer (Arrow Génériques)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Conc. conc. dec. no. 07-MC-06 of December 11, 2007 relating to a request for precautionary measures presented by Arrow Génériques Issues related to pharmaceutical products continue to occupy the agenda of the Competition Council. Indeed, the Competition Council has truly pre-empted an area that has been in the news most recently as the European Commission launched on 15 January 2008 a sector inquiry into the pharmaceutical industry that was prompted by "indications that competition may not be playing its full role in European pharmaceutical markets: fewer new pharmaceuticals are appearing on the market and the entry of generic pharmaceuticals sometimes

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Anne Wachsmann, Interim measures: The French Competition Council enjoins a pharmaceutical company to abstain from disparaging practices against a generic medicines manufacturer (Arrow Génériques), 11 December 2007, Concurrences N° 1-2008, Art. N° 15306, pp. 117-118

Visites 3799

All reviews